Technological and scientific successes still happen in America. But Biden's IRA attaches an anchor, becoming heavier year by year, to the pace of medical progress and wondrous health benefits Americans have enjoyed. Trump administration proposals, e.g., “most favored nation” reference pricing, patent valuation taxes, a patent royalty tax, will only slow U.S. innovation.

More than 20 conservative groups urged senior White House officials to support the PTO's proposed "Revision to Rules of Practice before the Patent Trial and Appeal Board." Special interests that have weaponized PTAB vigorously oppose the rule's improved fairness, efficiency and predictability in PTAB proceedings.

As we prepare to celebrate America’s 250th birthday, many Americans may not realize that the push to secularize our inherently Christian founding principles — including attacks on protections for the divinely endowed right to own the fruits of one’s labor — threatens the progress, creativity and competition inherent to our exceptional republic.

CPR joined other conservative groups in support of the American Music Fairness Act. In a letter before Kiss's Gene Simmons testified at a Senate Judiciary Committee hearing, they endorsed requiring radio stations to pay royalties on the music they play.

For those in Congress who value innovation as the lifeblood of American economic and technological

leadership, the signals from bipartisan lawmakers and the U.S. Patent and Trademark Office could not be clearer. It's time for lawmakers, especially Republicans, to seize this opportunity and move forward boldly on propatent legislation.

The UK's government takeover of standard-essential patent licensing assaults U.S. participants in the standards-development process. It devalues superior technologies while handing China the ability to win with patent quantity over quality.

Commerce Dept. must abandon its avant-garde policy proposal and uphold America’s longstanding model of rewarding competitive domestic invention with democratized, merit-based patents and full fruits of one's labor.

More than 30 organizations warn Commerce Secretary Howard Lutnick that a patent tax would undermine innovation benefits and undermine the tax cut benefits in President Trump's One Big Beautiful Bill Act.

Foreign countries with government-run health systems underpay for American-made drugs. The administration must employ robust trade policies and tactics to cudgel foreign freeloaders to pay their fair share.

The Democrats' dreadful "Inflation Reduction Act" is causing consumers' health premiums, coinsurance, and deductibles to go up, while its Rx price controls reduce innovation. So why is Trump pushing socialist Most Favored Nation drug price controls?

The domestic judicial chaos around patent eligibility puts American innovation, competitiveness, and economic and national security at stake. It's time for PERA.

In Special 301 report, the U.S. Trade Rep must fight back against blatant foreign theft and restore strong IP enforcement that puts America and South Carolina first.

PTAB has an open secret. Its own ends don't meet. In fact, PTAB’s failure to cover its own costs not only distorts the unit's decision making, PTAB gets subsidized by the PTO fees of patent applicants and patent owners.

Policy failures undermine American innovation and cripple R&D at home through price controls and “democratizing” IP. Pres. Trump’s support for IP protections and fair competition may boost U.S. ingenuity.

Conservatives seek course correction for U.S. competitiveness and innovation lead.

PREVAIL and PERA will spark an explosion of opportunity — one in which the next AI application or medical discovery isn't hobbled by ill-considered barriers to IP protection.

S. 2780 upends the IP system. Mandating identical disclosure to FDA and PTO risks patents and trade secrets.

Coalition urges Senate Judiciary Committee to pass two bipartisan patent bills to strengthen patents and promote American innovation.

Conservative leaders call on members of Congress to take bipartisan action to confront the growing threat from China when it comes to technology and research.

Restoring patent rights—namely through access to injunctive relief—would help reverse courts’ adverse effects and boost IP’s market value.

CPR’s James Edwards talks IP’s importance on CFIF’s new podcast IP Protection Matters.

From land deeds to patents, societies that respect property rights and enable people to accumulate property and protect it from theft thrive.

The legal apparatus in place to protect innovators is paramount for protecting America's culture of innovation and its place at the forefront in creating new technologies. 

A new study finds that two centuries of U.S. innovation leadership is faltering because of judges’ rulings that allow infringers to keep benefiting commercially from purloined inventions.

Global piracy affects the livelihoods of millions of people. It steals from those holding U.S. jobs in film and TV. Under the 1998 Digital Millennium Copyright Act, it’s costly and time-consuming to fight piracy.

The wildly successful, innovation-fostering Bayh-Dole contains no reference to prices of eventual products in connection with the law’s march-in provision or anything else.

Several lawmakers with experience and expertise in IP spotted reasons for concern with PAPA. PAPA was being fast-tracked, taking a leap away from the Founders’ democratized, merit-based patent system.

March-in introduces extensive uncertainty about patents remaining exclusive for product development and commercialization efforts using private investment dollars.

The Global Innovation Policy Center’s new IP principles espouse the importance of IP for America’s innovation, security and prosperity. 

Two bipartisan bills would restore some patent reliability. Other legislation introduced or seeking a sponsor threatens to reduce patent reliability and America’s global leadership in innovation versus China. 

Quiet title is essential to property rights—whether land where the EPA asserts unconstitutionally broad “navigable waters” regulations or by unfair eminent domain.

The EC 's regulatory framework hampers standard-essential patents. The regulatory train wreck will harm U.S. and European innovators and help China's competitiveness.